UR8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Urogen Pharma Ltd

Watchlist Manager

Watchlist

Price: 36.34 EUR -0.16%

Market Cap: €1.3B

U	Urogen Pharma Ltd F:UR8	IL
	Bc Technology Group Ltd F:9D2	CN
	Air T Inc F:GXT	US
	Cogelec SA F:5TL	FR

Profitability Summary

Urogen Pharma Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

91%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

88% > 91%

Negative Operating Margin

-35%

Negative 3Y Average Operating Margin

-97%

Operating Margin is Increasing

-105% > -35%

Negative Net Margin

-52%

Negative 3Y Average Net Margin

-130%

Net Margin is Increasing

-150% > -52%

Negative Free Cash Flow Margin

-84%

Negative 3Y Average Free Cash Flow Margin

-113%

Free Cash Flow Margin is Increasing

-118% > -84%

Exceptional ROE

86%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-228%

ROIC is Increasing

-204% > -79%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.